Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Chemical Reviews · 26.02.2025 · 125 (4) · 2120-2183
DOI: 10.1021/acs.chemrev.4c00595 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Reviews, online erschienen am 17.01.2025. Verfasst von Lisha Ou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, California 94305, United States. Hauptthemen laut MEDLINE: Proteins, Proteolysis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 502 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
The nascent field of targeted protein degradation (TPD) could revolutionize biomedicine due to the ability of degrader molecules to selectively modulate disease-relevant proteins. A key limitation to the broad application of TPD is its dependence on small-molecule ligands to target proteins of interest. This leaves unstructured proteins or those lacking defined cavities for small-molecule binding out of the scope of many TPD technologies. The use of proteins, peptides, and nucleic acids (otherwise known as "biologics") as the protein-targeting moieties in degraders addresses this limitation. In the following sections, we provide a comprehensive and critical review of studies that have used proteins and peptides to mediate the degradation and hence the functional control of otherwise challenging disease-relevant protein targets. We describe existing platforms for protein/peptide-based ligand identification and the drug delivery systems that might be exploited for the delivery of biologic-based degraders. Throughout the Review, we underscore the successes, challenges, and opportunities of using protein-based degraders as chemical biology tools to spur discoveries, elucidate mechanisms, and act as a new therapeutic modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Stanford University, Stanford, California 94305, United States.
- Sarafan ChEM-H Institute, Stanford University, Stanford, California 94305, United States.
- Department of Chemical Engineering, Stanford University, Stanford, California 94305, United States.
- Department of Microbiology & Immunology, Stanford School of Medicine, Stanford, California 94305, United States.
ORCID-Profile: Laura M K Dassama
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Heart, Lung, and Blood Institute
- Stanford University
Zitieren
APA
Ou, L., Setegne, M. T., Elliot, J., Shen, F., & Dassama, L. M. K. (2025). Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. Chemical Reviews, 125(4), 2120-2183. https://doi.org/10.1021/acs.chemrev.4c00595
Vancouver
Ou L, Setegne MT, Elliot J, Shen F, Dassama LMK. Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. Chemical Reviews. 2025;125(4):2120-2183. doi:10.1021/acs.chemrev.4c00595
BibTeX
@article{Ou2025,
author = {Ou, Lisha and Setegne, Mekedlawit T and Elliot, Jeandele and Shen, Fangfang and Dassama, Laura M K},
title = {Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics},
journal = {Chemical Reviews},
year = {2025},
volume = {125},
number = {4},
pages = {2120--2183},
doi = {10.1021/acs.chemrev.4c00595}
}
EUVIMED